Forma Therapeutics Holdings Inc

NASDAQ:FMTX   10:07:00 AM EDT
10.54
+0.36 (+3.54%)
Earnings Announcements

Forma Therapeutics Holdings Inc Reports Second Quarter 2022 Financial Results

Published: 08/05/2022 12:01 GMT
Forma Therapeutics Holdings Inc (FMTX) - Forma Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update.
Forma Therapeutics Holdings Inc - Cash Balance of $395.9 Million Positions Company With Runway Through Q3 of 2024.
Forma Therapeutics Holdings Inc - Qtrly Loss per Share $1.10.
Revenue is expected to be $1.08 Million
Adjusted EPS is expected to be -$1.05

Next Quarter Revenue Guidance is expected to be $0.58 Million
Next Quarter EPS Guidance is expected to be -$1.02

More details on our Analysts Page.